Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATM | Q13315 | 2/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | PARP1 | P09874 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13475327 | 1.00 | ATM (0.35) | ATMALDH1A1MEN1KMT2AL3MBTL1 | |
| SCHEMBL8224891 | 0.83 | ATM (0.36) | ATMALDH1A1MEN1KMT2AUSP2 | |
| SCHEMBL22534100 | 0.83 | ATM (0.36) | ATMALDH1A1MEN1KMT2AUSP2 | |
| SCHEMBL16578256 | 0.80 | ALDH1A1 (0.35) | ATMALDH1A1MEN1KMT2AL3MBTL1 | |
| SCHEMBL28400350 | 0.80 | USP2 (0.44) | ATMALDH1A1MEN1KMT2AUSP2 | |
| SCHEMBL28398203 | 0.80 | USP2 (0.41) | ATMALDH1A1MEN1KMT2AUSP2 | |
| SCHEMBL31207346 | 0.79 | ATM (0.36) | ATMUSP2 | |
| SCHEMBL8199208 | 0.78 | ATM (0.34) | ATMALDH1A1MEN1KMT2AUSP2 | |
| SCHEMBL16288379 | 0.78 | ALDH1A1 (0.38) | ATMALDH1A1MEN1KMT2AL3MBTL1 | |
| SCHEMBL15083263 | 0.78 | ALDH1A1 (0.38) | ATMALDH1A1MEN1KMT2AL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070021349-A1 | Orthogonally protected bifunctional amino acid | SCHERING AG (DE) | 2007-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070021349-A1 | Orthogonally protected bifunctional amino acid | BCAT1, BCAT2, DNPEP | ATM 4121/4885ALDH1A1 2939/4885MEN1 772/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.